# Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma

> **NCT01050790** · NA · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 17 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT01050790
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-08
- **Final completion:** 2016-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-06-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050790, "Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01050790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*